Cold-Related Age-Adjusted Mortality Rates Rose From 1999 to 2022
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 23, 2024 -- From 1999 to 2022, there was an increase in cold-related age-adjusted mortality rates (AAMRs), according to a research letter published online Dec. 19 in the Journal of the American Medical Association.
Michael Liu, from the Beth Israel Deaconess Medical Center in Boston, and colleagues assessed trends in cold-related mortality using the U.S. Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research platform. Death certificates from 1999 to 2022 in which cold was recorded as an underlying or contributing cause of death were examined.
The researchers found that between 1999 and 2022, there were 63,550,429 deaths in the United States, of which 0.06 percent had cold recorded as an underlying or contributing cause of death. Cold-related AAMRs increased from 0.44 to 0.92 per 100,000 persons from 1999 to 2022 (109 percent increase). During the study period, there was a 3.4 percent annual increase seen in the cold-related AAMR, with a nonsignificant increase from 1999 to 2017 (annual percent change [APC], 1.0 percent), followed by a significant annual increase from 2017 to 2022 (APC, 12.1 percent). Adults aged 75 years or older had the highest cold-related AAMRs (4.23 per 100,000 persons in 2022); the largest annual increase between 1999 and 2022 was seen for adults aged 45 to 74 years (APC, 4.8 percent). Males and females had significant increases during the study period, but males had higher AAMRs than females.
"Cold-related mortality rates more than doubled in the United States between 1999 and 2022," the authors write. "Prior research suggests that cold temperatures account for most temperature-related mortality."
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-24 12:00
Read more
- FDA Approves First Generic of GLP-1 Receptor Agonist Victoza (liraglutide injection) to Lower Blood Sugar in Patients with Type 2 Diabetes
- Insurer Anthem Rescinds Anesthesia Policy Change After Backlash
- Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
- FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
- Twice-Yearly Injection 96% Effective in Preventing HIV Infection
- FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions